tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMY Stock Latest News

Bristol-Myers Squibb Completes Key Study on Hypertrophic Cardiomyopathy in Japan
Company AnnouncementsBristol-Myers Squibb Completes Key Study on Hypertrophic Cardiomyopathy in Japan
2h ago
BMY
Bristol-Myers Squibb’s Phase 3 Study on Iberdomide: A Potential Game-Changer in Multiple Myeloma Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s Phase 3 Study on Iberdomide: A Potential Game-Changer in Multiple Myeloma Treatment
2h ago
BMY
Bristol-Myers Squibb’s New Study on BMS-986504: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s New Study on BMS-986504: A Potential Game-Changer in Cancer Treatment
2h ago
BMY
Bristol-Myers Squibb’s Promising Study on Deucravacitinib for Sjögren’s Syndrome
PremiumCompany Announcements
Bristol-Myers Squibb’s Promising Study on Deucravacitinib for Sjögren’s Syndrome
2h ago
BMY
Bristol-Myers Squibb’s KRAS G12C Study Update: Implications for Investors
PremiumCompany Announcements
Bristol-Myers Squibb’s KRAS G12C Study Update: Implications for Investors
2h ago
BMY
Bristol Myers’ sNDA for Sotyktu in psoriatic arthritis accepted by FDA
PremiumThe FlyBristol Myers’ sNDA for Sotyktu in psoriatic arthritis accepted by FDA
1d ago
BMY
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game Changer?
Premium
Company Announcements
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game Changer?
4d ago
BMY
Bristol-Myers Squibb’s Promising Phase 3 Study on Idiopathic Pulmonary Fibrosis Treatment
Premium
Company Announcements
Bristol-Myers Squibb’s Promising Phase 3 Study on Idiopathic Pulmonary Fibrosis Treatment
4d ago
BMY
Bristol-Myers Squibb’s New Lung Cancer Trial: A Potential Game Changer?
PremiumCompany Announcements
Bristol-Myers Squibb’s New Lung Cancer Trial: A Potential Game Changer?
4d ago
BMY
Bristol-Myers Squibb’s Phase 1 Study on BMS-986446: Key Insights for Investors
PremiumCompany Announcements
Bristol-Myers Squibb’s Phase 1 Study on BMS-986446: Key Insights for Investors
4d ago
BMY
Bristol-Myers Squibb’s Neoantigen Vaccine Study: A Potential Game-Changer for Blood Cancer Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s Neoantigen Vaccine Study: A Potential Game-Changer for Blood Cancer Treatment
4d ago
BMY
Bristol-Myers Squibb’s Milvexian Study: A Potential Game-Changer in Cardiovascular Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s Milvexian Study: A Potential Game-Changer in Cardiovascular Treatment
4d ago
BMY
Bristol Myers says Phase 3 INDEPENDENCE trial for Reblozyl did not meet endpoint
PremiumThe FlyBristol Myers says Phase 3 INDEPENDENCE trial for Reblozyl did not meet endpoint
4d ago
BMY
Bristol-Myers Squibb (BMY) and Pfizer (PFE) Stocks Jump on Eliquis Drug Discount
Premium
Market News
Bristol-Myers Squibb (BMY) and Pfizer (PFE) Stocks Jump on Eliquis Drug Discount
5d ago
BMY
PFE
Bristol-Myers Squibb’s KarXT Study: A Potential Game-Changer in Schizophrenia Treatment
Premium
Company Announcements
Bristol-Myers Squibb’s KarXT Study: A Potential Game-Changer in Schizophrenia Treatment
5d ago
BMY
Bristol-Myers Squibb’s New Study on KarXT: A Potential Game-Changer for Bipolar-I Disorder
PremiumCompany Announcements
Bristol-Myers Squibb’s New Study on KarXT: A Potential Game-Changer for Bipolar-I Disorder
5d ago
BMY
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
5d ago
GE
BLK
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game-Changer?
PremiumCompany Announcements
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game-Changer?
5d ago
BMY
Bristol-Myers Squibb’s New Study on Lung Cancer Treatment: What Investors Need to Know
PremiumCompany Announcements
Bristol-Myers Squibb’s New Study on Lung Cancer Treatment: What Investors Need to Know
5d ago
BMY
Bristol-Myers Squibb’s Psoriasis Study Termination: Market Implications
PremiumCompany AnnouncementsBristol-Myers Squibb’s Psoriasis Study Termination: Market Implications
5d ago
BMY
Bristol-Myers Squibb’s New Psoriasis Study: What Investors Need to Know
Premium
Company Announcements
Bristol-Myers Squibb’s New Psoriasis Study: What Investors Need to Know
5d ago
BMY
Bristol-Myers Squibb’s Phase 3 Alzheimer’s Study: Market Implications
Premium
Company Announcements
Bristol-Myers Squibb’s Phase 3 Alzheimer’s Study: Market Implications
5d ago
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >